According to a recent LinkedIn post from Alpha Aesthetics Partners, the company is highlighting LexRx as its fifteenth partner, describing it as a nurse practitioner–owned aesthetic practice based in Massachusetts. The post notes LexRx’s multi-location footprint in Boston and Nantucket and emphasizes the leadership of founder and CEO Alexa Nicholls Costa, who has experience in emergency medicine and plastic surgery at Massachusetts General Hospital.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post also underscores Alexa Nicholls Costa’s role as a nationally recognized educator and Key Opinion Leader, citing her faculty positions with Evolus Academy and Galderma’s GAIN Business program. It further mentions her Inject With Lex training platform, which is said to support aesthetic injectables education at institutions such as Boston College, Columbia University, and the University of North Carolina at Chapel Hill.
For investors, the addition of a clinically focused, education-oriented partner suggests Alpha Aesthetics Partners may be expanding its portfolio with practices that have both regional scale and professional influence. This could enhance the group’s overall brand equity, support standardized clinical practices across its network, and potentially improve patient acquisition and retention economics.
The emphasis on LexRx’s educational reach may also indicate strategic positioning within the medical aesthetics ecosystem, where training and KOL relationships can influence product adoption and procedural trends. If Alpha Aesthetics Partners can leverage this expertise across its partner practices, it may strengthen negotiating leverage with suppliers and support longer-term growth in procedure volumes and ancillary revenues.

